| Revenues | |
| Revenues - related party | 1.51M |
| Total revenues | 4.39M |
| Cost of revenues | 3.76M |
| Gross profit | 623.99K |
| Loss on equity investment | |
| Selling expenses | 414.15K |
| General and administrative expenses | 981.78K |
| Total operating expenses | 1.43M |
| Operating loss | |
| Other income | 0 |
| Interest income | 268 |
| Total other income | |
| Loss from continuing operations before income taxes and noncontrolling interest | |
| Loss from discontinued operations | |
| Gain on disposal of discontinued operations | |
| Total loss from discontinued operations | |
| Loss before income taxes and noncontrolling interest | |
| Income taxes | 0 |
| Net loss | -833.17K |
| Less: loss attributable to noncontrolling interest | |
| Net loss attributable to Sunwin International Neutracueticals, Inc. | |
| Net loss | -833.17K |
| Gain on foreign currency translation | |
| Total Comprehsneive income | |
| Loss from continuing operations | |
| Loss from discontinue operations | |
| Loss per common share | -0.01 |
| Weighted average common shares outstanding - basic and diluted | |
| Loss from continuing operations, net of tax | -810.99K |
| Loss from discontinued operations, net of tax | |
| Net loss attributable to Sunwin International Neutracueticals, Inc. | |